NL7909199A - Farmaceutisch preparaat voor het behandelen van nieuw- vormingsziekten en werkwijzen voor het bereiden ervan. - Google Patents
Farmaceutisch preparaat voor het behandelen van nieuw- vormingsziekten en werkwijzen voor het bereiden ervan. Download PDFInfo
- Publication number
- NL7909199A NL7909199A NL7909199A NL7909199A NL7909199A NL 7909199 A NL7909199 A NL 7909199A NL 7909199 A NL7909199 A NL 7909199A NL 7909199 A NL7909199 A NL 7909199A NL 7909199 A NL7909199 A NL 7909199A
- Authority
- NL
- Netherlands
- Prior art keywords
- thiazolidine
- carboxylic acid
- pharmaceutically acceptable
- acceptable salt
- agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US97172978 | 1978-12-21 | ||
| US05/971,729 US4384001A (en) | 1978-12-21 | 1978-12-21 | Treatment of tumors with thiazolidine-4-carboxylic acid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL7909199A true NL7909199A (nl) | 1980-06-24 |
Family
ID=25518727
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL7909199A NL7909199A (nl) | 1978-12-21 | 1979-12-20 | Farmaceutisch preparaat voor het behandelen van nieuw- vormingsziekten en werkwijzen voor het bereiden ervan. |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US4384001A (sv) |
| JP (1) | JPS55115822A (sv) |
| AU (1) | AU5390579A (sv) |
| BE (1) | BE880744A (sv) |
| CA (1) | CA1149284A (sv) |
| DE (1) | DE2951050A1 (sv) |
| DK (1) | DK542979A (sv) |
| ES (1) | ES487052A0 (sv) |
| FR (1) | FR2444459A1 (sv) |
| GB (1) | GB2039736B (sv) |
| IL (1) | IL58948A0 (sv) |
| IT (1) | IT1193348B (sv) |
| LU (1) | LU82013A1 (sv) |
| NL (1) | NL7909199A (sv) |
| SE (1) | SE7910300L (sv) |
| ZA (1) | ZA796918B (sv) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE53332B1 (en) * | 1980-03-14 | 1988-10-26 | Efamol Ltd | Pharmaceutical compositions |
| JPS57128625A (en) * | 1981-01-30 | 1982-08-10 | Rikagaku Kenkyusho | Carcinostatic |
| US4335210A (en) * | 1981-02-11 | 1982-06-15 | Cornell Research Foundation | Method of producing L-cysteine |
| FR2547728B1 (fr) * | 1983-06-24 | 1986-05-02 | Riker Laboratories Inc | Medicament a base d'acide d thiazolidine carboxylique |
| FR2547729B1 (fr) * | 1983-06-24 | 1986-05-02 | Riker Laboratories Inc | Medicament a base d'acide dl thiazolidine carboxylique |
| ATE80801T1 (de) * | 1984-12-18 | 1992-10-15 | Clark Pharma Dev | Antitumorzusammensetzungen enthaltend ein reaktionsprodukt zwischen einem cytotoxischen aldehyd und penicillamin und deren verwendung zur herstellung von arzneimitteln. |
| JPH066578B2 (ja) * | 1985-12-27 | 1994-01-26 | 三共株式会社 | チアゾリジン誘導体 |
| JPH01170063U (sv) * | 1988-05-11 | 1989-11-30 | ||
| JPH0467539U (sv) * | 1990-10-18 | 1992-06-16 | ||
| ES2092539T3 (es) * | 1991-01-10 | 1996-12-01 | Transcend Therapeutics Inc | Uso de derivados de la tiazolidina-4-carboxilato para el tratamiento de enfermedades pulmonares. |
| ES2277787B1 (es) * | 2006-01-02 | 2008-06-16 | Universidad De Cadiz | Empleo de tioprolina en tratamientos de reduccion de peso corporal. |
-
1978
- 1978-12-21 US US05/971,729 patent/US4384001A/en not_active Expired - Lifetime
-
1979
- 1979-12-12 GB GB7942753A patent/GB2039736B/en not_active Expired
- 1979-12-13 IL IL58948A patent/IL58948A0/xx unknown
- 1979-12-14 SE SE7910300A patent/SE7910300L/sv unknown
- 1979-12-17 AU AU53905/79A patent/AU5390579A/en not_active Abandoned
- 1979-12-18 IT IT28170/79A patent/IT1193348B/it active
- 1979-12-19 ES ES487052A patent/ES487052A0/es active Granted
- 1979-12-19 CA CA000342263A patent/CA1149284A/en not_active Expired
- 1979-12-19 BE BE0/198657A patent/BE880744A/fr not_active IP Right Cessation
- 1979-12-19 DK DK542979A patent/DK542979A/da unknown
- 1979-12-19 LU LU82013A patent/LU82013A1/fr unknown
- 1979-12-19 FR FR7931158A patent/FR2444459A1/fr active Granted
- 1979-12-19 DE DE19792951050 patent/DE2951050A1/de not_active Withdrawn
- 1979-12-20 ZA ZA00796918A patent/ZA796918B/xx unknown
- 1979-12-20 JP JP16495079A patent/JPS55115822A/ja active Granted
- 1979-12-20 NL NL7909199A patent/NL7909199A/nl not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JPS55115822A (en) | 1980-09-06 |
| GB2039736A (en) | 1980-08-20 |
| FR2444459B1 (sv) | 1983-04-01 |
| IL58948A0 (en) | 1980-03-31 |
| CA1149284A (en) | 1983-07-05 |
| IT7928170A0 (it) | 1979-12-18 |
| SE7910300L (sv) | 1980-06-22 |
| ES8102108A1 (es) | 1980-12-16 |
| AU5390579A (en) | 1980-06-26 |
| ES487052A0 (es) | 1980-12-16 |
| LU82013A1 (fr) | 1981-02-03 |
| BE880744A (fr) | 1980-06-19 |
| ZA796918B (en) | 1980-11-26 |
| FR2444459A1 (fr) | 1980-07-18 |
| GB2039736B (en) | 1983-04-13 |
| IT1193348B (it) | 1988-06-15 |
| DE2951050A1 (de) | 1980-07-10 |
| DK542979A (da) | 1980-06-22 |
| JPS6328045B2 (sv) | 1988-06-07 |
| US4384001A (en) | 1983-05-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SK137996A3 (en) | Cancer treatment and metastasis prevention | |
| NL7909199A (nl) | Farmaceutisch preparaat voor het behandelen van nieuw- vormingsziekten en werkwijzen voor het bereiden ervan. | |
| US6407125B1 (en) | Pharmacological agent and method of treatment | |
| US6579891B1 (en) | Agent and method for prevention and treatment of cancer in animals | |
| US20060074063A1 (en) | Pharmacological agent and method of treatment | |
| CN111346081B (zh) | 包含正戊酸、吲哚丙酸和正丁酸钠的药物组合物的新用途 | |
| US6403618B1 (en) | Agent and method for controlling angiogenesis | |
| CN115463118A (zh) | 和厚朴酚在制备治疗或预防毛细血管瘤的药物中的用途 | |
| CN108685892B (zh) | 绿原酸及其组合物在制备治疗鳞状细胞癌的药物中的用途 | |
| AU709620B2 (en) | New applications of lysozyme dimer | |
| DE60032915T2 (de) | Gallium komplexe von 3-hydroxy-4-pyronen zur behandlung von durch intrazelluläre prokaryoten, dns- und retro-viren verursachten infektionen | |
| Taliaferro | The Role of the Spleen and the Lymphoid-macrophage System in the Quinine Treatment of Gallinaceum Malaria: I. Acquired Immunity and Phagocytosis | |
| JPS6379824A (ja) | 制癌剤 | |
| US6441009B1 (en) | Agent and method of preventing and treating heavy metal exposure and toxicity | |
| NL9300065A (nl) | Samenstelling voor het versnellen van wondgenezing. | |
| KR20060038387A (ko) | 화학요법을 받고 있는 암 환자를 치료하는 방법 | |
| Boughattas et al. | Modulation of cisplatin chronotoxicity related to reduced glutathione in mice | |
| RU2178693C2 (ru) | Противовирусное средство для наружного применения на основе гиалуроновой кислоты | |
| CN113456643B (zh) | 一种含普那布林的药物组合及其应用 | |
| NL8501840A (nl) | Inhibitie van tumorontwikkeling. | |
| WO2023204380A1 (ko) | 생리활성물질 전달체 | |
| RU2426531C1 (ru) | Жидкая водная фармацевтическая композиция амброксола и фармацевтический препарат на ее основе, предназначенные для лечения заболеваний дыхательных путей с образованием вязкой мокроты (варианты) | |
| RU2282437C1 (ru) | Средство для лечения болезней суставов | |
| RU2681546C1 (ru) | Способ экстренной профилактики клещевого вирусного энцефалита | |
| US20130079416A1 (en) | Homeopathic medicament comprising phenacetin for the treatment of cancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A85 | Still pending on 85-01-01 | ||
| BV | The patent application has lapsed |